Clonal analysis of gliomas

Human Pathology

Volumn 28, Issue 10, 1997, Pages 1166-1179

  Kattar, Mireille M ^b   Kupsky, William J ^b   Shimoyama, Rie K ^b   Vo, Trieu D ^b   Olson, Matthew W ^b   Bargar, Geoffrey R ^b   Sarkar, Fazlul H ^a  

^a HARPER UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

Autopsy; Glioma; Gliomatosis cerebri; HUMARA; Microsatellite instability; X linked clonality

Indexed keywords

ANALYTIC METHOD; ARTICLE; ASTROCYTOMA; AUTOPSY; CLONAL ANERGY; DNA CONTENT; GENE AMPLIFICATION; GLIOMA; HUMAN; HUMAN TISSUE; MOLECULAR GENETICS; STEM CELL; X CHROMOSOME INACTIVATION; X CHROMOSOME LINKAGE;

EID: 0030764834     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90255-0     Document Type: Article

References (84)

1. Burger PC, Kleihues P: Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies. Cancer 63:2014-2023, 1989
2. Scherer HJ: The frequency of gliomas having variable histologic features. Journal belge de biologie et de psychiatrie 38:783-787, 1938
3. Bigner DD: Biology of gliomas: Potential clinical implications of glioma cellular heterogeneity. Neurosurgery 9:320-326, 1981
4. Shapiro JR, Yung WK, Shapiro WR. Isolation, karyotype and clonal growth of heterogeneous subpopulations of human gliomas. Cancer Res 41:2349-2359, 1981
5. Coons SW, Johnson PC, Shapiro JR: Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma. Cancer Res 55:1569-1577, 1995
6. Coons SW, Johnson PC: Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index. J Neuropathol Exp Neurol 52:609-618, 1993
7. Dalrymple SJ, Parisi JE, Roche PC, et al: Changes in proliferating cell nuclear antigen expression in glioblastoma multiforme cells along a stereotactic biopsy trajectory. Neurosurgery 35:1036-1045, 1994
8. Stavrou D, Bise K, Groeneveld J, et al: Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies. Anticancer Res 9:1489-1496, 1989
9. Reifenberger G, Deckert M, Wechsler W: Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumors. Acta Neuropathol 78:166-175, 1989
10. Strommer K, Hamou MF, Diggelman H, et al: Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas. Acta Neurochir 107:82-87, 1990
11. Schiffer D, Giordana MT, Germano I, et al: Anaplasia and heterogeneity of GFAP expression in gliomas. Tumori 72:163-170, 1986
12. Coons SW, Johnson PC: Regional heterogeneity of the DNA content of human gliomas. Cancer 72:3052-3060, 1993
13. Shapiro JR, Mehta BM, Ebrahim SA, et al: Tumor heterogeneity and intrinsically chemoresistent subpopulations in freshly resected human malignant gliomas, in Sudilovsky O, Pitot HC, Liotta LA (eds): Boundaries Between Promotion and Progression During Carcinogenesis. New York, NY, Plenum Publishing Corp 1991, pp 243-262
14. Benedixtsson G, Blomquist E, Carlsson J: Heterogeneity in cell loss and frequency of slow growing colonies of human glioma cell lines: Some effects of radiation. Anticancer Res 9:1483-1488, 1989
15. Scherer HJ: The forms of growth in gliomas and their practical significance. Brain 63:1-35, 1940
16. Russell DS, Rubinstein LJ: Pathology of Tumours of the Nervous System (ed 5). Baltimore, MD, Williams & Wilkins, 1989, pp 46-47, 219-227, 114-117, 766-770
17. Schober R, Mai JK, Volk B, et al: Gliomatosis cerebri: Bioptical approach and neuropathologic verification. Acta Neurochir 113:131-137, 1991
18. Artigas J, Cervos-Navarro J, Iglesias JR, et al: Gliomatosis cerebri: Clinical and histological findings. Clin Neuropathol 4:135-148, 1985
19. Barnard RD, GeddesJF: The incidence of multifocal cerebral gliomas, a histologic study of large hemisphere sections. Cancer 60:1519-1531, 1987
20. Batzdorf U, Malamud N: The problem of multicentric gliomas. J Neurosurg 20:122-136, 1963
21. Jomin M, Lesoin F, Lozes G, et al: Les gliomes à foyers multiples: A propos de 10 observations. Neurochirugie 29:411-426, 1983
22. Scherer HJ: Cerebral astrocytomas and their derivatives. Am J Cancer 40:159-198, 1940
23. James CD, Carlbom E, Dumanski JP, et al: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48:5546-5551, 1988
24. Lang FF, Miller DC, Koslow M, et al: Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 81:427-436, 1994
25. Wong AJ, Ruppert JM, Bigner SH, et al: Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci U S A 89:2965-2969, 1992
26. Williams GT, Wynford-Thomas D: How may clonality be assessed in human tumours? Histopathology 24:287-292, 1994
27. Hecht BK, Turc-Carel C, Chatel M, et al: Chromosomes in gliomastosis cerebri. Genes Chromosom Cancer 14:149-153, 1995
28. Berkman RA, Clark WC, Saxena A, et al: Clonal composition of glioblastoma multiforme. J Neurosurg 77:432-437, 1992
29. Morse RP, Darras BT, Ye Z, et al: Clonal analysis of human astrocytomas. J Neurooncol 21:151-157, 1994
30. Burger PC, Heinz R, Shibata T, et al: Topographic anatomy and CT correlations in the untreated glioblastoma. J Neurosurg 68:698-704, 1988
31. NazzarroJM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high grade astrocytomas in adults. J Neurosurg 73:331-344, 1990
32. Fialkow PJ: Clonal origin of human tumors. Biochim Biophys Acta 458:283-321, 1976
33. Hecht F, Hecht BK: Clonal selection: In the beginning a cell was chosen. Cancer Genet Cytogenet 59:79, 1992
34. Namba, H, Ross JL, Goodman D, et al: Solitary polyclonal autonomous thyroid nodule: A rare cause of childhood hyperthyroidism. J Clin Endocrinol Metab 72:1108-1112, 1991
35. Fialkow PJ, Jackson CE, Block MA, et al: Multicellular origin of parathyroid adenomas. N EnglJ Med 297:696-698, 1977
36. Delabie J, Tierens A, Weisenburger DD, et al: Nodular sclerosis Hodgkin's disease: Lineage and clonality determination using a single-cell assay. Blood 84:3291-3298, 1994
37. Barsky SH, Grossman DA, Ho J, et al: The multifocality of bronchioloalveolar lung carcinoma: Evidence and implications of a multiclonal origin. Mod Pathol 7:633-640, 1994
38. Allen RC, Zoghbi HY, Moseley AB, et al: Methylation of Hpa II and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X-chromosome inactivation. Am J Hum Genet 51:1229-1239, 1992
39. Busque L, Zhu J, DeHart D, et al: An expression based clonality assay at the human androgen receptor locus (HUMARA) on chromosome X. NAR 22:697-698, 1994
40. Mashal RD, Lester SC, SklarJ: Clonal analysis by study of X-chromosome inactivation in formalin-fixed paraffin-embedded tissue. Cancer Res 53:4676-4679, 1993
41. Kleihues P, Burger PC, Scheithauer BW: Histologic Typing of Tumours of the Central Nervous System. New York, NY, Springer-Verlag, 1993
42. Daumas-Duport C, Scheithauer BW, O'Fallon J, et al: Grading of astrocytomas: A simple and reproducible method. Cancer 62:2152-2165, 1988
43. Lyon MF: Gene action in the X-chromosome of the mouse. Nature 190:372, 1961
44. Vogelstein B, Fearon ER, Hamilton SR, et al: Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res 47:4806-4813, 1987
45. Gale RE, Wheadon H, Linch DC: X-chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and post-chemotherapy females. Br J Haematol 79:193-197, 1991
46. Fey MF, Peter HJ, Hinds HL, et al: Clonal analysis of human tumors with Mβ27, a highly informative polymorphic X chromosomal probe. J Clin Invest 89:1438-1444, 1992
47. Mutter GL, Chaponot ML, Fletcher JA: A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers. Am J Pathol 146:501-508, 1995
48. Willman CL, Busque L, Griffith BB, et al: Langerhans' cell histiocytosis (histiocytosis X): A clonal proliferative disease. N Engl J Med 331:154-160, 1994
49. Ashworth B, Gordon A: Leptomeningeal gliomatosis. J Neurol Neurosurg Psychiatry 57:471-473, 1994
50. Hamilton SR, Liu B, Parsons RE, et al: The molecular basis of Turcot' syndrome. N EnglJ Med 332:839-847, 1995
51. Mutter GL, Boynton KA: PCR bias in amplification of androgen receptor allele, a trinucleotide repeat marker used in clonality studies. NAR 8:1411-1418, 1995
52. Shibata D: Extraction of DNA from paraffin-embedded tissue for analysis by polymerase chain reaction: New tricks from an old friend. HUM PATHOL 25:561-563, 1994
53. Salazar OM, Rubin P: The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. J Radia Oncol Biol Phys 1:627-637, 1976
54. Silbergeld DL, Rostomily RC, Alvord CE: The cause of death in patients with gliomas is multifactorial: Clinical factors and autopsy findings in 117 cases of supratentorial glioblastoma in adults. J Neuro oncol 10:179-185, 1991
55. Burger PC, Dubois PJ, Schold CS, Jr et al: Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58: 159-169, 1983
56. Chicoine MR, Silbergeld DL: Assessment of brain tumor cell motility in vivo and in vitro. J Neurosurg 82:615-622, 1995
57. Bernstein JJ, Goldberg WJ, Laws ER Jr: Human malignant astrocytoma xenografts migrate in rat brain: A model for central nervous system cancer research. J Neurosci Res 22:136-143, 1989
58. Laws ER, Goldberg WJ, Bernstein JJ: Migration of human malignant astrocytoma cells in the mammalian brain: Scherer revisited. Int J Dev Neurosci 11:691-697, 1993
59. Quinonero, J, Colin C, Villaroya H, et al: Migration of astrocytes after grafting; Migration pathways, differentiation and survival of macroglial cells from a xenograft implanted into the thalamus of newborn mice. Int J Dev Neurosci 11:545-554, 1993
60. LaChapelle F, Gumpel M, Jacque C, et al: Transplantation of CNS fragments into the brain of shiverer mutant mice: Extensive myelination by implanted oligodendrocytes. I. Immunohistochemical studies. Dev Neurosci 6:325-334, 1984
61. Harvey AR, Fan Y, Connor AM, et al: The migration and intermixing of donor and host glia on nitrocellulose polymers implanted into critical lesion cavities in adult mice and rats. Int J Dev Neurosci 11:569-581, 1993
62. Johnson PC, Drayer BP, Rigamonti D, et al: Defining the extent of infiltrating glioblastoma multiforme (GBM) : A comparison of postmortem magnetic resonance imaging (MRI) with histopathology. J Neuropathol Exp Neurol 46:389, 1987 (abstr)
63. Kyritsis AP, Yung WK, Leeds NE, et al: Multifocal cerebral gliomas associated with secondary malignancies. Lancet 339:1229-1230, 1992
64. Courville CB: Multiple primary tumors of the brain: Review of the literature and report of twenty-one cases. Am J Cancer 26:703-731, 1936
65. Budka H, Podreka I, Reisner T, et al: Diagnostic and pathomorphological aspects of glioma multiplicity. Neurosurg Rev 3:233-241, 1980
66. Jacobs IJ, Kohler MF, Wiseman RW, et al: Clonal origin of epithelial ovarian carcinoma: Analysis by loss of heterozygosity, p53 mutation and X-chromosome inactivation. J Natl Cancer Inst 84:1793-1798, 1992
67. Collins VP, James CD: Gene and chromosomal alterations associated with the development of human gliomas. FASEB J 7:926-930, 1993
68. Magnani I, Guerneri S, Polio B, et al: Increasing complexity of the karyotype in 50 human gliomas: Progressive evolution and de novo occurrence of cytogenetic alterations. Cancer Genet Cytogenet 75:77-89, 1994
69. Biernat W, Aguzzi A, Sure V, et al: Identical mutations of the p53 tumor suppressor gene in the gliomatous and sarcomatous components of gliosarcomas suggest a common origin from glial cells. J Neuropathol Exp Neurol 54:651-656, 1995
70. Kraus JA, Koopmann J, Kaskel P, et al: Shared allelic losses on chromosome 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54:91-95, 1995
71. Mitelman F: Catalog of Chromosomal Aberrations in Cancer (ed 5). New York, NY, Wiley-Liss, 1994, pp 3759-3764
72. Hecht BK, Turc-Carel C, Chatel M, et al: Cytogenetics of malignant gliomas: II. The sex chromosomes with reference to X isodisomy and the role of numerical X/Y changes. Cancer Genet Cytogenet 84:9-14, 1995
73. Paulus W, Bayas A, Ott G, et al: Interphase cytogenetics of glioblastoma and gliosarcoma. Acta Neuropathol 88:420-425, 1994
74. Heim S, Mandahl N, Jin Y, et al: Trisomy 7 and sex chromosome loss in human brain tissue. Cytogenet Cell Genet 52:136-138, 1989
75. Edwards A, Hammond HA, Jin L, et al: Genetic variation of five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 12:241-253, 1992
76. Kyritsis AP, Bondy ML, Xiao M, et al: Germline p53 gene mutations in subsets of glioma patients. J Natl Cancer Inst 86:344-349, 1994
77. Dams E, Van de Kelft JZ, Martin JJ, et al: Instability of microsatellites in human gliomas. Cancer Res 55:1547-1549, 1995
78. Gibbons MC, Rosenberg J, Jedlicka AE, et al; Microsatellite instability in gliomas. J Neuropathol Exp Neurol 54:420, 1995 (Abstr)
79. Arnoldus EP, Noordermeer IA, Peters B, et al: Interphase cytogenetics of brain tumors. Genes Chromosom Cancer 3:101-107, 1994
80. Ransom DT, Ritland SR, Kimmel DW, et al: Cytogenetics and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes Chromosom Cancer 5:348-356, 1992
81. Ransom DT, Ritland SR, Moertel CA, et al: Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligoastrocytomas. Genes Chromoson Cancer 5:357-376, 1992
82. Bells MJ, deCampos JM, Kusak ME, et al: Molecular analysis of genomic abnormalities in gliomas. Cancer Genet Cytogenet 73:122-129, 1994
83. Sidransky D, Mikkelsen T, Schwechheimer K, et al: Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 355:846-847, 1992
84. Fults D, Brockmeyer D, Tullous MW, et al: p53 mutation and loss of heterozygosity on chromosome 17 and 10 during human astrocytoma progression. Cancer Res 52:674-679, 1992